XTX Markets’s Savara SVRA Stock Holding History

XTX Markets’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,765	Closed	-$15K	–	249
2020 Q3	$15K	Buy	+13,765	New	+$23.5K	0.07%	99

Other funds holding SVRA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Markets's SVRA Position: Q4 2020 in Review

XTX Markets sold out of Savara (SVRA) in Q4 2020, closing a stake of 13,765 shares — an estimated $15K sold.

XTX Markets first reported a position in SVRA in Q3 2020 and held it in 1 quarter. The position peaked at $15K in Q3 2020. 66 funds tracked by Wall St. Rank hold SVRA as of Q4 2020.

XTX Markets reported no remaining Savara position as of Q4 2020 after selling out during the quarter.
XTX Markets sold 13,765 Savara shares in Q4 2020, an estimated $15K.
XTX Markets first reported a position in Savara in Q3 2020 and held it in 1 quarter.
XTX Markets's Savara position peaked at $15K in Q3 2020.
66 funds tracked by Wall St. Rank held Savara as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.